Suppr超能文献

乙型肝炎相关肝硬化合并肝细胞癌切除术后的长期预后

Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis.

作者信息

Poon R T, Fan S T, Lo C M, Liu C L, Ng I O, Wong J

机构信息

Centre of Liver Disease, Department of Surgery, University of Hong Kong, Queen Mary Hospital, Hong Kong, China.

出版信息

J Clin Oncol. 2000 Mar;18(5):1094-101. doi: 10.1200/JCO.2000.18.5.1094.

Abstract

PURPOSE

The optimum management of hepatocellular carcinoma (HCC) associated with cirrhosis has not yet been clarified. Very few data are available in the literature regarding the prognosis after resection of HCC associated with hepatitis B virus (HBV)-related cirrhosis. This study evaluated the long-term results and prognostic factors after resection of HCC complicating HBV-related cirrhosis.

PATIENTS AND METHODS

One hundred forty-six patients with HBV-related Child's A or B cirrhosis who had undergone resection of HCC over a 10-year period were prospectively studied for long-term results. They were compared with 155 noncirrhotic patients with HBV-related HCC resected in the same period.

RESULTS

The overall survival results of cirrhotic patients after resection of HCC were comparable to those of noncirrhotic patients (5-year survival, 44.3% v 45.6%, respectively; P =.216), but the former group had significantly smaller tumors. Stratified according to tumor size, the survival results were similar between cirrhotic and noncirrhotic patients with tumors </= 5 cm (5-year survival, 60.7% v 61.7%, respectively; P =.327) but were worse in cirrhotic compared with noncirrhotic patients with tumors greater than 5 cm (5-year survival, 27.8% v 39.5%, respectively; P =.034). Stage by stage, there were no significant differences in survival results between cirrhotic and noncirrhotic patients. Preoperative serum AST level greater than 100 IU/L (P =.004), perioperative transfusion (P =.015), and venous invasion (P <.001) were independent adverse prognostic factors.

CONCLUSION

The prognosis after resection of HCCs less than 5 cm in patients with compensated HBV-related cirrhosis was comparable to that of noncirrhotic patients, which suggests that surgical resection may be considered a first-line treatment for these patients. Patients with underlying active hepatitis as indicated by a high preoperative transaminase level are less favorable candidates for resection. Further studies are needed to define the relative roles of resection and transplantation for HCC associated with hepatitis B cirrhosis.

摘要

目的

肝细胞癌(HCC)合并肝硬化的最佳治疗方案尚未明确。关于乙型肝炎病毒(HBV)相关肝硬化合并HCC切除术后的预后,文献中的数据非常少。本研究评估了HBV相关肝硬化合并HCC切除术后的长期结果及预后因素。

患者与方法

前瞻性研究了146例在10年期间接受HCC切除术的HBV相关Child A或B级肝硬化患者的长期结果。将他们与同期切除的155例非肝硬化HBV相关HCC患者进行比较。

结果

HCC切除术后肝硬化患者的总体生存结果与非肝硬化患者相当(5年生存率分别为44.3%和45.6%;P = 0.216),但前一组肿瘤明显较小。根据肿瘤大小分层,肿瘤≤5 cm的肝硬化和非肝硬化患者的生存结果相似(5年生存率分别为60.7%和61.7%;P = 0.327),但肿瘤大于5 cm的肝硬化患者与非肝硬化患者相比生存结果更差(5年生存率分别为27.8%和39.5%;P = 0.034)。逐阶段来看,肝硬化和非肝硬化患者的生存结果没有显著差异。术前血清AST水平大于100 IU/L(P = 0.004)、围手术期输血(P = 0.015)和静脉侵犯(P < 0.001)是独立的不良预后因素。

结论

代偿性HBV相关肝硬化患者中,肿瘤小于5 cm的HCC切除术后预后与非肝硬化患者相当,这表明手术切除可被视为这些患者的一线治疗方法。术前转氨酶水平高提示存在潜在活动性肝炎的患者不太适合进行切除。需要进一步研究来确定切除和移植在HBV肝硬化合并HCC中的相对作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验